Yushen Wu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
-
- Circular RNAs in diseases 3
- Co-authors
- Huapeng Lin (9 shared papers)Guosheng Ren (10 shared papers)Ziying Yi (10 shared papers)Yunhai Li (6 shared papers)Hongzhong Li (5 shared papers)Beilei Zeng (4 shared papers)Jiazheng Sun (4 shared papers)Yuanyuan Chen (3 shared papers)
- Journals
- Medicine (3 papers)Biochemical and Biophysical Research Communications (2 papers)Cancer Management and Research (2 papers)Frontiers in Immunology (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yushen Wu
25 papers receiving 554 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 123
- Oncology 182
- Hepatology 21
- Internal Medicine 9
- Immunology 57
Countries citing papers authored by Yushen Wu
This map shows the geographic impact of Yushen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yushen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yushen Wu more than expected).
Fields of papers citing papers by Yushen Wu
This network shows the impact of papers produced by Yushen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yushen Wu. The network helps show where Yushen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yushen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 93 | |
| 2 | 2022 | 70 | |
| 3 | 2022 | 43 | |
| 4 | 2020 | 41 | |
| 5 | 2019 | 39 | |
| 6 | 2018 | 35 | |
| 7 | 2020 | 31 | |
| 8 | 2019 | 26 | |
| 9 | 2018 | 17 | |
| 10 | 2019 | 16 | |
| 11 | 2018 | 15 | |
| 12 | 2018 | 15 | |
| 13 | 2020 | 15 | |
| 14 | 2023 | 15 | |
| 15 | 2021 | 14 | |
| 16 | 2018 | 14 | |
| 17 | 2019 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2018 | 8 |
About Yushen Wu
Yushen Wu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 25 papers that have together received 564 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (123 citations), Oncology (182 citations), Hepatology (21 citations), Internal Medicine (9 citations) and Immunology (57 citations). Yushen Wu has collaborated with scholars based in China and United States. Frequent co-authors include Huapeng Lin, Guosheng Ren, Ziying Yi, Yunhai Li, Hongzhong Li, Beilei Zeng, Jiazheng Sun, Yuanyuan Chen, Xiaoyi Wang and Huimin Du. Their work appears in journals such as Medicine, Biochemical and Biophysical Research Communications, Cancer Management and Research, Frontiers in Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.